Leaderboards/Natural Compounds in Disease Treatment

Natural Compounds in Disease Treatment

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Caifeng Deng
First Affiliated Hospital of Chengdu Medical College
2
Longxia Li
Fudan University
3
Wenmin Pi
Beijing University of Chinese Medicine
4
S.M. Kawish
Hindu College of Pharmacy
5
Hannah Ying Lim
National University of Singapore
6
Caiwei Yu
Australian National University
7
Jiachen Ge
Hebei Medical University
8
Jiahang Tian
Xi'an Jiaotong University
9
Yanxia Xiao
Chinese Academy of Medical Sciences & Peking Union Medical College
10
Zhongwei Yuan
Northeast Agricultural University

Papers

1
Publication in Particle & Particle Systems Characterization (2024) [61 citations, W4400122832]
Particle & Particle Systems Characterization|2024
61 cit.
2
Triptolide-induced cuproptosis is a novel antitumor strategy for the treatment of cervical cancer
Cellular & Molecular Biology Letters|2024
41 cit.
3
Publication in Chemical Engineering Journal (2024) [38 citations, W4402436766]
Chemical Engineering Journal|2024
38 cit.
4
Sequential Targeting Chondroitin Sulfate‐Bilirubin Nanomedicine Attenuates Osteoarthritis via Reprogramming Lipid Metabolism in M1 Macrophages
Advanced Science|2025
23 cit.
5
Genetically engineered chondrocyte-mimetic nanoplatform attenuates osteoarthritis by blocking IL-1β and restoring sirtuin-3
Science Advances|2025
12 cit.
6
Single chiral center epimerization-modulated multi-carrier-free oral hydrogel for remolding inflammatory microenvironment via PI3K/Akt/NF-κB and MAPK signaling pathways
Bioactive Materials|2025
1 cit.
7
[Anti-tumor effect of metal ion-mediated natural small molecules carrier-free hydrogel combined with CDT/PDT].
PubMed|2025
0 cit.
8
Single-Cell Analysis Links C7+ Cancer-Associated Fibroblasts with Incomplete Resection in Platinum-Sensitive Relapsed Ovarian Cancer
Biomedicines|2025
0 cit.
9
Publication in International Journal of Women s Health (2026) [W7125972444]
International Journal of Women s Health|2026
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Rohini Trivedi
Mohanlal Sukhadia University
2
Xianjun Yu
Hubei University of Medicine
3
Li He
Lanzhou University
4
Ke Tan
Zhejiang Shuren University
5
Xiaoqiang Xiang
Fudan University
6
Feihai Shen
Sun Yat-sen University
7
Meng Yu
Huazhong Agricultural University
8
Lu Xu
National Center for Supercomputing Applications
9
Buzhen Tan
Jiangxi Maternal and Child Health Hospital
10
Hongtao Du
Xinyang Normal University

Papers

1
Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer
Journal of Nanobiotechnology|2022
226 cit.
2
An acid-responsive MOF nanomedicine for augmented anti-tumor immunotherapy via a metal ion interference-mediated pyroptotic pathway
Biomaterials|2023
127 cit.
3
Glutamine Antagonist Synergizes with Electrodynamic Therapy to Induce Tumor Regression and Systemic Antitumor Immunity
ACS Nano|2022
97 cit.
4
Review on biogenic synthesis of copper nanoparticles and its potential applications
Inorganic Chemistry Communications|2023
71 cit.
5
Impact of high, low, and non-optimum temperatures on chronic kidney disease in a changing climate, 1990–2019: A global analysis
Environmental Research|2022
54 cit.
6
Phyto-fabrication of silver nanoparticles and their catalytic dye degradation and antifungal efficacy
Frontiers in Chemistry|2022
53 cit.
7
Constructing an Ultra-Rapid Nanoconfinement-Enhanced Fluorescence Clinical Detection Platform by Using Machine Learning and Tunable DNA Xerogel “Probe”
Analytical Chemistry|2023
29 cit.
8
Population pharmacokinetic/pharmacodynamic modeling and exposure-response analysis of ciprofol in the induction and maintenance of general anesthesia in patients undergoing elective surgery: A prospective dose optimization study
Journal of Clinical Anesthesia|2023
29 cit.
9
Impact of high temperature on road injury mortality in a changing climate, 1990–2019: A global analysis
The Science of The Total Environment|2022
25 cit.
10
A novel mitochondrial unfolded protein response-related risk signature to predict prognosis, immunotherapy and sorafenib sensitivity in hepatocellular carcinoma
APOPTOSIS|2024
25 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Bharat B. Aggarwal
Max Super Speciality Hospital
2
Luyong Zhang
Guangdong Pharmaceutical University
3
Ashok K. Saluja
Qingdao University
4
Wei Gao
Guangxi University
5
Peter E. Lipsky
Ampel BioSolutions (United States)
6
Zhenzhou Jiang
China Pharmaceutical University
7
Yoshihisa Takaishi
Tokushima University
8
Isabel L. Bazzocchi
Universidad de La Laguna
9
Gautam Sethi
National University of Singapore
10
Xiangliang Yang
Wuhan National Laboratory for Optoelectronics

Papers

1
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
New England Journal of Medicine|2000
3k cit.
2
Anticancer potential of curcumin: preclinical and clinical studies.
PubMed|2003
2.6k cit.
3
Cyclooxygenase in biology and disease
The FASEB Journal|1998
2.5k cit.
4
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
The Lancet|1999
2.4k cit.
5
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
PubMed|2004
1.4k cit.
6
Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)
Journal of Biological Chemistry|1995
1.4k cit.
7
Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B.
Proceedings of the National Academy of Sciences|1996
1.1k cit.
8
Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation
The Journal of Immunology|2007
1.1k cit.
9
Human tumor necrosis factor. Production, purification, and characterization.
Journal of Biological Chemistry|1985
919 cit.
10
Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon
Nature|1985
882 cit.

Reagents for Natural Compounds in Disease Treatment

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 63

DDX6/RCK Antibody

Cited in 11 papers
#9407$368
View Evidence →
Cell Signaling TechnologyEvidence 65

Akt3 (L47B1) Mouse Monoclonal Antibody

Cited in 9 papers
#8018$148,348
View Evidence →
Cell Signaling Technology

PathScan® Cleaved Notch1 (Val1744) Sandwich ELISA Kit

Cited in 9 papers
#7194$66,129,740
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

DcR3 Antibody

Cited in 19 papers
#4758$136,317
View Evidence →
Cell Signaling Technology

Gefitinib

Cited in 14 papers
#4765$197
View Evidence →
Cell Signaling TechnologyEvidence 66

Phospho-Stat1 (Tyr701) (58D6) Rabbit Monoclonal Antibody (Alexa Fluor® 647 Conjugate)

Cited in 14 papers
#8009$191,500
View Evidence →